Beyond weight loss: toward phenotype-guided, regionally calibrated interventions in polycystic ovary syndrome (PCOS)

Abstract

Polycystic ovary syndrome (PCOS) management mainly revolves around general lifestyle modifications that almost always include weight loss, an approach that fails to reflect the biological and ethnic diversity of the condition. Clinical and epidemiological evidences are suggestive of PCOS-associated metabolic and reproductive risk varying markedly across phenotypes and populations. These include obese, hyperandrogenic presentations to metabolically vulnerable women with lean-PCOS. Thus, universal lifestyle advice frequently delivers inconsistent or limited benefit. In this article, we propose a phenotype-guided and regionally informed approach to lifestyle intervention that incorporates hormonal, metabolic, and contextual factors, and this may allow PCOS care to move toward more precise and clinically meaningful intervention.

Background

Polycystic ovary syndrome (PCOS) is a highly prevalent endocrine-metabolic disorder with reproductive and metabolic consequences. International guidelines on PCOS [American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE)] recommend lifestyle modification with weight-loss as first-line therapy. These are largely generic without adequately reflecting marked biological and ethnic heterogeneity of PCOS subtypes [1]. In Middle East and North Africa (MENA) populations, metabolic risks are seen to increase with increasing adiposity, while studies in South and East Asia show that incidence of PCOS is not always dependent on general obesity markers and they often do not respond significantly to weight-focused strategies [2], [3], [4]. These patterns highlight limitations of body mass index (BMI)-centric approaches and support phenotype-guided, regionally adjusted strategies.

The limits of generic lifestyle advice in PCOS

PCOS guidelines suggest lifestyle modification as PCOS management with benefits for weight and metabolic outcomes [1], but they also acknowledge the limitation that there is very scanty evidence that such management significantly improves fertility parameters and reverse long-term PCOS. This leaves broad gap in decision making for PCOS management strategies caused by pooling biologically heterogeneous PCOS phenotypes under general global guideline [5]. A pilot study showed that with a smaller hypocaloric diet only 40 % of the participants (overweight PCOS women) exhibited a favorable phenotypic shift [6]. This suggests that failure to incorporate phenotypic context to intervention may contribute to variable response.

Biological heterogeneity and the case for phenotype-guided lifestyle

The established Rotterdam criteria categorize PCOS into four phenotypes based on combinations of hyperandrogenism, oligo/anovulation, and polycystic ovarian morphology (Table 1). These phenotypes have varying degrees of metabolic risk and are supposed to have different approach of treatment [7], [8], [9]. Hyperandrogenic phenotypes (A–C) are more consistently associated with insulin resistance and metabolic disordering than the milder phenotype D [7], 8]. This can be supported by a study in China on a large cohort data that demonstrated greater adiposity and insulin resistance in hyperandrogenic phenotypes compared with non-hyperandrogenic types [9]. Metabolic disturbance linked to androgen excess may respond differently to dietary composition or exercise intensity than milder phenotypes, where aggressive weight loss may offer limited benefit. With evolving facilities, integrating molecular markers (such as microRNA profiles) into stratified lifestyle models could also permit further genotype-phenotype interaction tailoring [10].

Table 1:

Integrating phenotypic and regional context into lifestyle intervention models for PCOS.

PCOS context	Key biological or regional feature	Limitations of generic lifestyle advice	Proposed phenotype-guided/regionally calibrated strategy	Expected benefit
Phenotype A (HA + OA + PCOM)	Highest insulin resistance and androgen excess	Weight-loss-centric models may inadequately address severe hyperinsulinemia and inflammation	Low-glycemic, insulin-sensitizing diet; HIIT or resistance training; adjunct metformin	Improved ovulatory function and reduced androgen load
Phenotype B (HA + OA)	Hyperandrogenic but less morphological change	Generic caloric restriction yields partial improvement only	Structured aerobic strength regimen; dietary modulation emphasizing insulin control	Enhanced reproductive and metabolic outcomes
Phenotype C (HA + PCOM)	Hyperandrogenic with preserved ovulation	Minimal benefit from weight loss alone	Anti-inflammatory, low-refined-carbohydrate diet; stress and sleep optimization	Lower androgen production and improved lipid profile
Phenotype D (OA + PCOM, non-HA)	Mild metabolic impairment (‘lean PCOS’)	Overemphasis on weight reduction may induce undernutrition	Focus on body-composition fitness; balanced macronutrient intake; strength-based activity	Maintenance of lean mass, stable ovulation, metabolic resilience
MENA region	High metabolic risk even at lower BMI; prevalent HA phenotypes	Western weight thresholds misclassify metabolic risk	Region-specific BMI/waist cut-offs; culturally adapted meal plans	Early metabolic control and improved adherence
South & Southeast Asia	High prevalence of lean or normoandrogenic PCOS	Caloric restriction ineffective; limited exercise environment	Home-based or telehealth activity programs; low-glycemic traditional diets	Improved insulin sensitivity and sustainable compliance
Europe/Western cohorts	Obesity-linked phenotypes dominate	Lifestyle models not extrapolatable to lean ethnic groups	Continue structured diet-exercise programs but validate phenotype stratification	Benchmark data for phenotype-specific global trials
Life-course approach	Adolescent and pre-conception windows critical for prevention	Late intervention misses early plasticity	Early metabolic screening; adolescent education; pre-conception counseling	Long-term disease modification and fertility optimization

HA, hyperandrogenism; OA, oligo/anovulation; PCOM, polycystic ovarian morphology; HIIT, high-intensity interval training; BMI, body mass index.

If we consider the PCOS-stratification from a life-course perspective, lifestyle interventions should be tailored as per the key periods of biological plasticity, such as adolescence, preconception, and midlife. Table 1 outlines how phenotypic and regional differences can guide more targeted lifestyle strategies beyond weight-focused approaches.

Regional and ethnic considerations: MENA, Southeast Asia, Europe & beyond

PCOS-models must confront geographical and ethnic heterogeneity to ensure the effectiveness of lifestyle interventions.

Middle East and North African (MENA) populations

Women in the Middle East manifest disproportionately higher rates of obesity, insulin resistance, and hyperandrogenism with hirsutism. Recent reports show high PCOS prevalence in the MENA region, around 13–20 % of global prevalence, and suggest that these populations may require more aggressive metabolic modulation [2], 11]. Further, population-specific reference genomes (such as the Qatar Genome project) highlight the need to account for regional allele frequencies in precision medicine approaches [11].

Southeast Asia/South Asia

In South and Southeast Asia, many women present with lean-PCOS with BMI within normal range, limiting the relevance of universal weight-loss focused advice. It is shown in a study that cultural dietary patterns and activity constraints further influence lifestyle feasibility, prompting development of tailored interventions such as the Individualized Lifestyle Intervention in PCOS (IPOS) trial [12]. This design reflects the reality that ‘lifestyle’ is not monolithic across regions.

Europe and Western cohorts

Most lifestyle management PCOS- guidelines fit the majority of Western cohorts from European and North American countries with higher baseline BMI, limiting its applicability to the minorities with leaner phenotypes. Although structured diet-exercise interventions improve selected reproductive outcomes, still some clinical features of PCOS persist in many women [1], 5]. These limitations underscore the need to adapt specific lifestyle strategies tailored according to the regional metabolic profiles, dietary traditions and practical constraints.

Building a phenotype-guided, life-course lifestyle framework

Following strategic pillars for PCOS classification are hereby proposed to move beyond lifestyle to life-course oriented management.

Stratified baseline assessment

At initial evaluation, a standard PCOS women should be adopted based on the phenotypes (A, B, C, D) (Table 1), insulin resistance metrics, adiposity distribution, androgen levels and specific life-course. This can be done using routinely available clinical and biochemical tools. Emerging molecular biomarkers (such as miRNAs, metabolomics) may serve as adjunctive or research-tier tools for refined stratification in specialized or future settings.

Adaptive and phenotype-specific interventions

Interventions should be based on the above baseline stratification as women with HA-dominant phenotypes might benefit more from low-glycemic, insulin-sensitizing diets, intermittent higher-intensity interval training (HIIT), or adjunctive low-dose metformin, while those with milder phenotypes (e.g. phenotype D) might benefit from moderate aerobic exercise and modest caloric adjustment focusing on body composition rather than strict weight loss, and on the other hand, for lean-PCOS phenotypes again insulin-sensitizing nutrition and strength training may be better than caloric restrictions.

Longitudinal feedback & adjustment to intervention

Behavior interventions should be treated like titratable therapeutics by quarterly monitoring intermediate markers like menstrual cyclicity, AMH, androgen levels, insulin, body composition. Intervention should be adjusted for its intensity and frequency based on the trajectory of monitored parameters, rather than static preset targets.

Cultural and regional tailoring

Interventions must align with regional diets, lifestyle constraints, and resource realities. Telemedicine and mHealth reminders may improve adherence (as seen in Spanish SMS-based arms) [5]. It is also seen that trials like IPOS exemplify adaptation to the South Asian contexts [12].

Early-life and preconception windows

Interventions during early life course (adolescence or before pregnancy) may have a stronger impact than treatment later in life. Early PCOS screening and supporting healthy habits in young women could help prevent worsening metabolic and reproductive problems over time.

Data sharing and global database

It is essential to establish global PCOS database stratified by phenotype, intervention type, and regional context, broadly these can be segregated into the MENA, Southeast Asia, Europe, and America. These databases should then go through rigorous meta-analyses and cross-validation of phenotype-specific responses to standardize region-specific interventions and management strategies.

Rigorous RCTs with phenotype arms

As previously discussed, the current PCOS guidelines are evolving and remains open to improvise recognizing the need to study lifestyle interventions in different PCOS subgroups [13]. Thus, future trials must also test the PCOS interventions within specific phenotypes.

Implications for practice and guideline Evolution

PCOS management and interventions are more likely to benefit patients if they are strategized as per the phenotypes build on regional factors like ethnicity, body composition, metabolic health etc. This approach will allow earlier recognition of ineffective strategies leading to timely adjustment of the management. Generic lifestyle advice often turns ineffective, whereas tailored guidance can improve patients’ expectations and engagement. In future, addressing lifestyle factors reflecting biological risk with emerging molecular tools may even help prevent the development of PCOS complications.

Conclusions

PCOS is a multifactorial condition needing effective management towards phenotype-guided, context-specific strategies, incorporating factors like life-courses, various body compositions and regional variation. The proposed strategic plans aim to strengthen the guidelines shifting towards precision in PCOS stratification and management.